We help high-net-worth investors make tax-efficient investments in life-changing medical technologies.
Tax-efficient investments
Norcliffe connects your capital with pioneering medical technologies that have the potential to transform lives and deliver meaningful returns.
We carefully identify and vet innovations on the brink of breakthrough, helping you make tax-efficient investments with confidence, purpose, and impact.
"When you fund a company working on a cure for a disease, you're not just investing in science - you’re investing in people’s lives."
funding rounds
2020
year established
£2M to £5M
Companies supported
11
Funds raised
£47M
With an impressive career spanning over 30 years in finance, Patricia brings a wealth of expertise in advisory, finance, and venture capital to her role.
With her unwavering dedication to supporting transformative innovations, Patricia is a driving force behind Norcliffe Capital’s success in the ever-evolving landscape of medtech and biotech tax-efficient investments.
Meet Patricia - CEO and founder
the face behind norcliffe
Notable Clients:
With decades of combined business experience in the life science sectors, Norcliffe Capital provides more than capital to support their investments. They use their experience and expertise to select UK based growth companies in their specialist sectors and support them throughout their commercial journey. Norcliffe Capital’s investors have the opportunity to invest directly in individual private companies in the life science sectors of medical technology and biotechnology.
investment portfolio
We passionately believe that the world-leading medical technology across the UK has the potential to transform the lives of patients and provide exceptional financial rewards for those with the vision to make lives better.
Simply put, we believe in “Profit with a Purpose”.
